Another study provided general guidelines for CPM by calculating the lifetime risk of CBC based on a published systematic review of age at first BC, BRCA1/2 gene mutation, family history of BC, ER status, ductal carcinoma in situ, and oophorectomy [34, 67]. This evidence concerns the gene BRCA1 and ductal breast carcinoma in situ.